We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News
Medica 2024
AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

GNA Biosolutions Reveals New Ultrafast PCR Platform at Medical Trade Show

By HospiMedica International staff writers
Posted on 13 Nov 2022
GNA Biosolutions GmbH (Martinsried, Germany), a molecular technology company, will showcase its new Pharos V8, the world's first laser PCR platform, at MEDICA 2017.

GNA Biosolutions specializes in sample-to-result applications across medical diagnostics, biosecurity, food safety, and life sciences. The company develops instruments, OEM modules and applications for ultrafast molecular assays based on proprietary technology protected by a comprehensive patent portfolio.

Image: The Pharos V8 laser PCR platform (Photo courtesy of GNA Biosolutions).
Image: The Pharos V8 laser PCR platform (Photo courtesy of GNA Biosolutions).

The Pharos V8, an ultrafast PCR instrument for in vitro research use, uses the patented Laser PCR technology, which operates on the same principles as conventional nucleic acid amplification with PCR (Polymerase Chain Reaction). However, Laser PCR uses nanomaterials to control temperature cycles at the nano scale, accelerating PCR reaction times by a factor of ten and opening the door for applications in multiple time-sensitive settings.

Some of the key features of the Pharos V8 include an open platform for universal PCR assay development, ultrafast real-time nucleic acid detection in 10 minutes or less, and intuitive interface with easy-to-use software that can be accessed remotely.

“We are excited to present our first Laser PCR platform, the Pharos V8, at this year's Medica,” said Frank Krieg-Schneider, CEO of GNA Biosolutions. “We believe the Pharos V8 will demonstrate the power of our patented technology to deliver ultrafast molecular results, and pave the way for additional platforms in development for diagnostic testing and point of care.”

Related Links:
GNA Biosolutions

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Platelet Concentration System
GPS III
New
Silver Member
Advanced 12-Lead Electrocardiograph with Printer
NECG SE-1200 Pro

Latest Medica 2017 News

TRILUX Medical and Mizuho to Showcase New Modular OR Solutions

Richard Wolf to Present Innovative System Solutions at Germany Trade Show

Randox to Showcase Future-Proofing Diagnostic Technology at Trade Fair